Get an early preview of the new iBridge Network

Access new technology search features and an extended innovation database with new transformative technologies
fed into the platform by our member Academic Institutions, Research Labs, SMEs, Startups


Prevotella and Coprococcus as human gut health enhancers. Specific case example: Autism

Arizona State University (AzTE)
posted on 06/26/2012

The human gut hosts millions of bacteria, which help balance the immune system, digest food, produce vitamins and promote gastrointestinal (GI) motility. Imbalances in the gut microbiome may contribute to immune and neurological disorders as well as GI problems. Given the crucial role of gut microorganisms in maintaining GI health and the increasing evidence of GI problems in autistic children, it is highly likely that there is a link between autism and gut microbiota.

While there have been reports to identify and characterize intestinal microflora, limited data are available to elucidate autism-related gut microbe composition, and none have successfully elucidated a link between gut microbiota and autism. This is important for accurate diagnosis as well as for treatment of autism-related GI problems and possibly other autistic symptoms. Especially, previous reports overlooked potentially beneficial gut flora that autistic children are missing.

Researchers at the Biodesign Institute of Arizona State University have developed a novel but simple method of assessing human gut health using microbial biomarkers present in stools. These microbial biomarkers may be used not only to assess human gut health, but to test and detect autism spectral disorders (ASD) in early stages. Moreover, these microorganisms may be used as probiotics to enhance human gut health and provide a beneficial enhancement for ASD treatment.

This technology provides for a versatile and simple method to gauge human gut health and detect early stage ASD. Plus, it presents a novel probiotic as a treatment for ASD or poor gut health.

Potential Applications

  • Assessment of human gut health
  • Early stage detection of ASD
  • Supplement to modify the gut microbiota in a beneficial way for patients with ASD or poor gut health
  • Assessment of probiotic treatment

Benefits and Advantages

  • Early stage ASD detection - individuals with ASD may have under-developed communication skills; biomarkers provide easier detection means
  • Assessment of gut health - using stool samples vs. more invasive means
  • May reduce ASD symptoms - using probiotic to build up healthy gut biome
  • May help with other gut disorders in the same fashion

Dowload Original PDF

For more information about the inventor(s) and their research, please see
Dr. Krajmalnik-Brown's directory webpage

Dr. LaBaer's departmental webpage

Innovation Details

File Number: M12-194L 

IP Protection

License Online

This innovation currently is not available for online licensing. Please contact Yash Vaishnav at Arizona State University (AzTE) for more information.

Request more info via email request more info

Case Manager:

Yash Vaishnav Yash Vaishnav

Innovations (211)

Download Technology Brief (PDF)

Followed By
Related Tags

Find more innovations

February 11, 2009

13,716 members 17,882 innovations 176 organizations


William Garner, M.D., MPH - CEO of Urigen, N.A., Inc.

"The iBridge Network provides an important additional pathway for entrepreneurs to access university innovations that may otherwise have been lost. The transparency of this pathway between entrepreneurs..."  read more...